(A) PNA+ GC clusters (original magnification, 10×) in NZM2328 mice (top) and PNA+ clusters without FDCs in DKO mice (bottom). (B). Percentage CD95+GL7+ B cells in CD19+ B cells in nephritic NZM and DKO mice. (C and D) CD95+GL7+ B cells include PNAhiCD38lo GC B cells and PNAloCD38+ memory cells. (E) Flow plots show the gating of splenic CD95+GL7+ B cells in CD19+ B cells from NZM and DKO mice and their LZ and DZ phenotype. (F and G) Bar graphs show the summary result of GL7 expression (F) and LZ/DZ ratio (G). (H) Percentage CCR6+CD38+ memory B cells in LZ CD95+GL7+CXCR4–CD86+ compartment in NZM and DKO mice. (I and J) Percentage (I) and number (J) of CCR6+CD38+ memory B cells in NZM and DKO mice. (K) Immunohistochemistry images (original magnification, 20×) show PD1hiCD4+ T cells in DZ of GCs of NZM (top) and scattered throughout the GC cluster in DKO (bottom) mice. (L) Immunohistochemistry images (original magnification, 20×) show Ki67+Bcl6+ B cells in GCs of NZM (top) and DKO (bottom) mice (representative of 3–4 mice per group). (M) Pie charts show mutation frequencies in VH sequences from CD95+GL7+ B cells from NZM (left) and DKO (right) mice. χ2, ***P < 0.001. (N and O) Percentage ANA-positive B cells in CD95+GL7+ GC B cells (N) and follicular IgM+IgD+ B cells (O). (P and Q) Bar graphs show the summary result of Bcl6 (P) and Bach2 (Q) expression on CD95+GL7+ GC B cells. NZM mice (white bars); DKO mice (gray bars). Dots on bar graphs represent individual mice. Immunohistochemistry representative of 3–5 mice per group. (B, D, F–J, N, and O) Mann-Whitney nonparametric t test, **P < 0.01, ***P < 0.001. (P and Q) ANOVA Kruskal-Wallis with Dunn’s multiple comparisons test, **P < 0.01.